Year |
Citation |
Score |
2015 |
Chen WH, Lecaros RL, Tseng YC, Huang L, Hsu YC. Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer. Cancer Letters. 359: 65-74. PMID 25596376 DOI: 10.1016/j.canlet.2014.12.052 |
0.451 |
|
2014 |
Tseng YC, Kan LP, Huang LY, Yin T, Yang YS, Lin JC, Siu LK. Successful treatment of a patient with ventriculoperitoneal shunt-associated meningitis caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae. The Tohoku Journal of Experimental Medicine. 233: 301-5. PMID 25142281 DOI: DN/JST.JSTAGE/tjem/233.301 |
0.314 |
|
2014 |
Tseng YC, Xu Z, Guley K, Yuan H, Huang L. Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases. Biomaterials. 35: 4688-98. PMID 24613050 DOI: 10.1016/j.biomaterials.2014.02.030 |
0.416 |
|
2013 |
Tseng YC, Yang A, Huang L. How does the cell overcome LCP nanoparticle-induced calcium toxicity? Molecular Pharmaceutics. 10: 4391-5. PMID 24032396 DOI: 10.1021/mp400028m |
0.355 |
|
2013 |
Xu Z, Ramishetti S, Tseng YC, Guo S, Wang Y, Huang L. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 172: 259-65. PMID 24004885 DOI: 10.1016/J.Jconrel.2013.08.021 |
0.543 |
|
2012 |
Liu Y, Tseng YC, Huang L. Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method? Pharmaceutical Research. 29: 3273-7. PMID 22806405 DOI: 10.1007/s11095-012-0818-1 |
0.39 |
|
2012 |
Chung C, Wang Y, Sheng W, Tseng Y, Dick T, Huang L, Robertson G. Abstract B10: Overcoming resistance to B-Raf targeting agents using LPD nanotechnology Clinical Cancer Research. 18: B10-B10. DOI: 10.1158/1078-0432.Mechres-B10 |
0.429 |
|
2010 |
Li J, Chen YC, Tseng YC, Mozumdar S, Huang L. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 142: 416-21. PMID 19919845 DOI: 10.1016/j.jconrel.2009.11.008 |
0.542 |
|
2009 |
Tseng YC, Huang L. Self-assembled lipid nanomedicines for siRNA tumor targeting. Journal of Biomedical Nanotechnology. 5: 351-63. PMID 20055081 |
0.446 |
|
2009 |
Tseng YC, Mozumdar S, Huang L. Lipid-based systemic delivery of siRNA. Advanced Drug Delivery Reviews. 61: 721-31. PMID 19328215 DOI: 10.1016/J.Addr.2009.03.003 |
0.394 |
|
Show low-probability matches. |